SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Lips P 2001 Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22: 477501.
  • 2
    Epstein S, Schneider AE 2005. Drug and hormone effects on vitamin D metabolism. In FeldmanD, PikeJW, GlorieuxFH (eds). Vitamin D, 2nd ed. Elsevier, Amsterdam, The Netherlands, pp. 12531291.
  • 3
    Lips P, van Ginkel FC, Netelenbos JC, Wiersinga A, van der Vijgh WJF 1990 Lower mobility and markers of bone resorption in the elderly. Bone Miner 9: 4957.
  • 4
    Lips P, Netelenbos JC, Jongen MJM, van Ginkel FC, Althuis AL, van Schaik CL, van der Vijgh WJF, Vermeiden JPW, van der Meer C 1982 Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Relat Res 4: 8593.
  • 5
    Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM 1995 Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10: 11771184.
  • 6
    Van der Meer IM, Karamali NS, Boeke AJ, Lips P, Middelkoop BJ, Verhoeven I, Wuister JD 2006 High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. Am J Clin Nutr 84: 350353.
  • 7
    Koutkia P, Chen TC, Holick MF 2001 Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med 345: 6667.
  • 8
    Vieth R, Pinto TR, Reen BS, Wong MM 2000 Vitamin D poisoning by table sugar. Lancet 359: 672.
  • 9
    Jacobus CH, Holick MF, Quig Shao MD, Chen TC, Holm IA, Kolodny JM, El-Hajj Fuleihan G, Seely EW 1992 Hypervitaminosis D associated with drinking milk. N Engl J Med 326: 11731177.
  • 10
    Kerstens PJSM, Van Ditzhuijsen Th JM, Van Tongeren JHM 1990 Megadoses vitamine D: Progressieve geneeskunde? Ned Tijdschr Geneeskd 134: 19591961.
  • 11
    Lips P, Chapuy MC, Dawson-Hughes B, Pols HAP, Holick MF 1999 An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 9: 394397.
  • 12
    Hollis BW 2005. Detection of vitamin D and its major metabolites. In: FeldmanD, PikeJW, GlorieuxFH (eds). Vitamin D, 2nd ed. Elsevier, Amsterdam, The Netherlands, pp. 931950.
  • 13
    Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R 2005 Estimates of optimal vitamin D status. Osteoporos Int 16: 713716.
  • 14
    Lips P 2004 Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89-90: 611614.
  • 15
    Patel S, Hyer S, Barron J 2007 Glomerular filtration rate is a major determinant of the relationship between, 25-hydroxyvitamin D and parathyroid hormone. Calcif Tissue Int 80: 221226.
  • 16
    Sahota O, Mundy MK, San P, Godber IM, Hosking DJ 2006 Vitamin D insufficiency and the blunted PTH response in established osteoporosis: The role of magnesium deficiency. Osteoporos Int 17: 10131021.
  • 17
    Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE 1982 Calcium homeostasis in immobilization: An example of resorptive hypercalciuria. N Engl J Med 306: 11361140.
  • 18
    Graafmans WC, Lips P, Ooms ME, van Leeuwen JPTM, Pols HAP, Uitterlinden AG 1997 The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res 12: 12411245.
  • 19
    Lips P, Wiersinga A, van Ginkel FC, Jongen MJM, Netelenbos JC, Hackeng WHL, Delmas PD, van der Vijgh WJF 1988 The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 67: 644650.
  • 20
    Dusso AS, Brown AJ, Slatopolsky EA 2005 Vitamin D and renal failure. In: FeldmanD, PikeJW, GlorieuxFH (eds). Vitamin D, 2nd ed. Elsevier, Amsterdam, The Netherlands, pp. 13131338.
  • 21
    Glorieux FH, St-Arnaud R 2005 Vitamin D pseudodeficiency. In: FeldmanD, PikeJW, GlorieuxFH (eds). Vitamin D, 2nd ed. Elsevier, Amsterdam, The Netherlands, pp. 11971205.
  • 22
    Drezner MK 2005 Clinical disorders of phosphate homeostasis. In: FeldmanD, PikeJW, GlorieuxFH (eds). Vitamin D, 2nd ed. Elsevier, Amsterdam, The Netherlands, pp. 11591186.
  • 23
    Liberman UA, Halabe A, Samuel R, Kauli R, Edelstein S, Weisman Y, Papapoulos SE, Clemens TL, Fraher LJ, O'Riordan JL 1980 End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet 3: 504506.
  • 24
    Papapoulos SE, Clemens TL, Fraher LJ, Lewin IG, Sandler LM, O'Riordan JLH 1979 1,25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet 1: 627630.
  • 25
    Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL 1981 Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 305: 440443.
  • 26
    Playford EG, Bansal AS, Looke DF, Whitby M, Hogan PG 2001 Hypercalcemia and elevated 1,25(OH)2D3 levels associated with disseminated mycobacterium avium infection in AIDS. J Infect 42: 157158.
  • 27
    Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS 2003 HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS 17: 513520.
  • 28
    Davies M, Hayes ME, Mawer EB, Lumb GA 1985 Abnormal vitamin D metabolism in Hodgkin's lymphoma. Lancet 1: 11861188.
  • 29
    Rosenthal N, Insogna KL, Godsall JW, Smaldone L, Waldron JA, Stewart AF 1985 Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab 60: 2933.
  • 30
    Hewison M, Kantorovich V, Liker HR, Van Herle AJ, Cohan P, Zehnder D, Adams JS 2003 Vitamin D-mediated hypercalcemia in lymphoma: Evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 18: 579582.
  • 31
    Bouillon RA, Auwerx JH, Lissens WD, Pelemans WK 1987 Vitamin D status in the elderly: Seasonal substrate deficiency causes, 1,25-dihydroxycholecalciferol deficiency. Am J Clin Nutr 45: 755763.
  • 32
    Papapoulos SE, Clemens TL, Fraher LJ, Gleed J, O'Riordan JLH 1980 Metabolites of vitamin D in human vitamin D deficiency: Effect of vitamin D3 or 1,25-dihydroxycholecalciferol. Lancet 2: 612615.
  • 33
    Netelenbos JC, Jongen MJM, van der Vijgh WJF, Lips P, van Ginkel FC 1985 Vitamin D status in urinary calcium stone formation. Arch Intern Med 145: 681684.